Bionema launches tender for marketing of biocontrol solutions

Bionema launches tender for marketing of biocontrol solutions

By: ICN Bureau

Last updated : January 08, 2024 7:29 pm



he company’s innovative formulation and delivery platform technology enable the development of products with 20-30% higher efficacy and productivity


Bionema Group, a leading developer of sustainable biocontrol solutions, has announced a tender for the marketing of their innovative range of environmentally friendly biological products. These solutions are designed to address crop protection and plant health management in the Agriculture, Sport Turf Amenity, Horticulture, Agriculture, and Forestry sectors.

As public awareness and concerns regarding the impact of agrochemicals (pesticides and fertilisers) on human health, biodiversity, soil health and the environment continue to rise, Bionema aims to provide a complete collection of more than 60 biological products and technology that offer effective, eco-friendly alternatives. This strategic move follows Bionema’s transformative deal with Syngenta in 2021, congealing their position as a world-leading biocontrol technology company.

Over the past 15 months, Bionema has undergone significant growth to meet the progressing needs of the market. Their different product range now includes Biocontrol, Biostimulants, Biofertiliser and Efficacy Booster customised to agriculture, horticulture, forestry, turf & amenities, and public health.

Dr Minshad Ansari, Founder and CEO of Bionema Group, expressed the company’s vision, said, “Our goal is to be at the forefront of Biological Agriculture technology innovator, reducing reliance on chemical pesticides. With changing global trends and increasing demands from consumers, society, and regulators, sustainable alternatives are urgently needed. For instance, consider the EU’s aspiring plan to ban 50% pesticides by 2030 and significantly increase organic farming. Achieving such targets requires innovative solutions like the ones we are introducing”.

The company’s innovative formulation and delivery platform technology enable the development of products with 20-30% higher efficacy and productivity compared to existing products.

Dr Ansari stressed, “While we are pleased to introduce our new products, our commitment to innovation and collaboration remains unwavering. We have achieved significant milestones, but our dedication to progress continues, and we firmly believe that the best is yet to come”.

Bionema Group Dr Minshad Ansari

First Published : January 08, 2024 12:00 am